Abstract

BackgroundGerminal matrix intraventricular hemorrhage (GM-IVH) is associated with cerebro-cerebellar damage in very preterm infants, leading to neurodevelopmental impairment. Penetration, from the intraventricular space, of extravasated red blood cells and extracellular hemoglobin (Hb), to the periventricular parenchyma and the cerebellum has been shown to be causal in the development of brain injury following GM-IVH. Furthermore, the damage has been described to be associated with the cytotoxic nature of extracellular Hb-metabolites. To date, there is no therapy available to prevent infants from developing either hydrocephalus or serious neurological disability. Mechanisms previously described to cause brain damage following GM-IVH, i.e., oxidative stress and Hb-metabolite toxicity, suggest that the free radical and heme scavenger α1-microglobulin (A1M) may constitute a potential neuroprotective intervention.MethodsUsing a preterm rabbit pup model of IVH, where IVH was induced shortly after birth in pups delivered by cesarean section at E29 (3 days prior to term), we investigated the brain distribution of recombinant A1M (rA1M) following intracerebroventricular (i.c.v.) administration at 24 h post-IVH induction. Further, short-term functional protection of i.c.v.-administered human A1M (hA1M) following IVH in the preterm rabbit pup model was evaluated.ResultsFollowing i.c.v. administration, rA1M was distributed in periventricular white matter regions, throughout the fore- and midbrain and extending to the cerebellum. The regional distribution of rA1M was accompanied by a high co-existence of positive staining for extracellular Hb.Administration of i.c.v.-injected hA1M was associated with decreased structural tissue and mitochondrial damage and with reduced mRNA expression for proinflammatory and inflammatory signaling-related genes induced by IVH in periventricular brain tissue.ConclusionsThe results of this study indicate that rA1M/hA1M is a potential candidate for neuroprotective treatment following preterm IVH.

Highlights

  • Germinal matrix intraventricular hemorrhage (GM-Intraventricular hemorrhage (IVH)) is a frequent complication of prematurity, which occurs in 25% of very low birth weight (VLBW) infants [1, 2]

  • Parallel sections were single immunolabeled for A1M, the hemorrhage marker Hb, and double-IF labeled for A1M and Hb or PSA-NCAM

  • In this study, we show that following i.c.v. administration of recombinant A1M (rA1M) in preterm rabbit pups with IVH, there is a wide distribution of rA1M in periventricular and cerebellar regions with high plasticity coupled with a high co-existence of deposited extracellular Hb

Read more

Summary

Introduction

Germinal matrix intraventricular hemorrhage (GM-IVH) is a frequent complication of prematurity, which occurs in 25% of very low birth weight (VLBW) infants [1, 2]. Extravasation of RBCs and Hb into CSF have been shown to result in deposition of Hb-metabolites on the cerebellar surface, leading to alteration of normal development of the cerebellar cortex and its related functions [30,31,32]. It seems that RBC rupture and release of extracellular Hb may be central in the development of irreversible brain damage following GM-IVH. Mechanisms previously described to cause brain damage following GM-IVH, i.e., oxidative stress and Hb-metabolite toxicity, suggest that the free radical and heme scavenger α1-microglobulin (A1M) may constitute a potential neuroprotective intervention

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call